MARKET

DVAX

DVAX

Dynavax Technolo
NASDAQ
15.50
+0.01
+0.06%
After Hours: 15.49 -0.01 -0.06% 19:06 02/06 EST
OPEN
15.49
PREV CLOSE
15.49
HIGH
15.50
LOW
15.49
VOLUME
2.01M
TURNOVER
--
52 WEEK HIGH
15.73
52 WEEK LOW
9.20
MARKET CAP
1.76B
P/E (TTM)
-41.3444
1D
5D
1M
3M
1Y
5Y
1D
BUZZ-OneSpaWorld jumps as co poised to join S&P SmallCap index
Reuters · 2d ago
OneSpaWorld Holdings Will Replace Dynavax Technologies In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On February 10,2026
Benzinga · 2d ago
OneSpaWorld to replace Dynavax in S&P 600 at open on 2/10
TipRanks · 2d ago
Assessing Dynavax Technologies (DVAX) Valuation After Recent Share Price Momentum And Ongoing Pipeline Investment
Simply Wall St · 4d ago
Weekly Report: what happened at DVAX last week (0126-0130)?
Weekly Report · 5d ago
Is Dynavax Technologies (DVAX) Pricing Reflect Its Biotech Role And Recent Share Performance
Simply Wall St · 5d ago
Sanofi Buyout Of Dynavax Recasts Adult Vaccine Growth For Shareholders
Simply Wall St · 6d ago
Weekly Report: what happened at DVAX last week (0119-0123)?
Weekly Report · 01/26 09:10
More
About DVAX
Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company developing and commercializing vaccines to help protect against infectious diseases. The Company has two commercial products: HEPLISAV-B vaccine (Hepatitis B Vaccine (Recombinant), Adjuvanted), and CpG 1018 adjuvant. The HEPLISAV-B vaccine is used for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose in-one-month adult hepatitis B vaccine. CpG 1018 adjuvant is used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines. The Company is advancing a pipeline of differentiated product candidates that leverage its CpG 1018 adjuvant to develop improved vaccines in indications with unmet medical needs. Its pipeline programs include Shingles vaccine program (Z-1018) and Plague vaccine program. Z-1018 is an investigational vaccine candidate being developed for the prevention of shingles in adults aged 50 and older.

Webull offers Dynavax Technologies Corp stock information, including NASDAQ: DVAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DVAX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DVAX stock methods without spending real money on the virtual paper trading platform.